Hydrofarm Holdings Group, Inc. (HYFM)
시가총액: 14.95M
국가: United States
산업: #Consumer_Specialties
섹터: #Consumer_Discretionary
홈페이지: https://www.hydrofarm.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 40.5M / 55.88M / -27.5% / -25.2% / 8.6%
2412: 37.3M / 41.07M / -9.2% / -20.9% / -15.2%
2409: 44M / 46.81M / -6.0% / -18.8% / -19.7%
2406: 54.79M / 53.91M / 1.6% / -13.1% / 1.1%
2403: 54.17M / -- / -- / -12.9% / 14.8%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -3.12 / -0.19 / -1542.1% / -1014.3% / 17.9%
2412: -3.8 / -0.24 / -1483.3% / -- / -1210.3%
2409: -0.29 / -0.21 / -38.1% / 34.1% / -37.2%
2406: -0.2113 / -0.213 / 0.8% / 24.5% / 24.5%
2403: -0.28 / -- / -- / 24.3% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 226.58M(-34.2%) / -1.42(77.6%)
2212: 344.5M(-28.1%) / -6.35(-2148.4%)
2112: 479.42M(40.1%) / 0.31(167.4%)
2012: 342.2M(--) / -0.46(--)

#HYFM

- 사업요약: Hydrofarm Holdings Group, Inc., together with its subsidiaries, manufactures and distributes controlled environment agriculture (CEA) equipment and supplies in...

Alico, Inc. (ALCO)
시가총액: 225.54M
국가: United States
산업: None
섹터: None
홈페이지: https://www.alicoinc.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 18M / 8M / 125.0% / -0.6% / 6.6%
2412: 16.89M / 11.5M / 46.9% / 20.8% / 1691.1%
2409: 943K / 400K / 135.8% / 38.7% / -93.1%
2406: 13.61M / 17.8M / -23.5% / 86.8% / -24.9%
2403: 18.11M / -- / -- / -14.9% / 29.5%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -14.58 / -0.28 / -5107.1% / -604.3% / -1115.0%
2412: -1.2 / -0.28 / -328.6% / -121.3% / 49.6%
2409: -2.38 / -0.4 / -495.0% / -- / -781.5%
2406: -0.27 / -0.25 / -8.0% / -117.3% / 87.0%
2403: -2.07 / -- / -- / -102.9% / -136.7%

- 연간 매출(YoY%), EPS(YoY%)
2309: 39.85M(-56.7%) / 0.24(-85.5%)
2209: 91.95M(-15.3%) / 1.65(-64.4%)
2109: 108.56M(17.4%) / 4.64(46.8%)
2009: 92.51M(--) / 3.16(--)

#ALCO

- 사업요약: Alico, Inc., together with its subsidiaries, operates as an agribusiness and land management company in the United States. The company operates in two segments, Alico Citrus, and Land Management and Other Operations. ...

Fate Therapeutics, Inc. (FATE)
시가총액: 118.62M
국가: United States
산업: #Biotechnology_Biological_Products_No_Diagnostic_Substances
섹터: #Health_Care
홈페이지: https://www.fatetherapeutics.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 1.63M / 876K / 86.1% / -15.3% / -12.4%
2412: 1.86M / 1.58M / 17.7% / 11.0% / -39.4%
2409: 3.07M / 1.24M / 147.6% / 57.9% / -54.7%
2406: 6.77M / 1.33M / 409.0% / 625.6% / 251.7%
2403: 1.93M / -- / -- / -96.7% / 14.9%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.32 / -0.39 / 17.9% / 31.9% / 27.3%
2412: -0.44 / -0.44 / 0.0% / -- / -10.0%
2409: -0.4 / -0.4165 / 4.0% / 13.0% / -21.2%
2406: -0.33 / -0.46 / 28.3% / 38.9% / 29.8%
2403: -0.47 / -- / -- / -147.4% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 63.53M(-34.0%) / -1.64(43.6%)
2212: 96.3M(72.4%) / -2.91(-29.9%)
2112: 55.85M(77.7%) / -2.24(-6.7%)
2012: 31.43M(--) / -2.1(--)

#FATE

- 사업요약: Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders world...

Mereo BioPharma Group plc (MREO)
시가총액: 397.5M
국가: United Kingdom
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://www.mereobiopharma.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 0.00 / 26.88M / -100.0% / -- / --
2412: 0.00 / 36.25M / -100.0% / -- / --
2409: 0.00 / 0.00 / -- / -- / --
2406: 0.00 / -- / -- / -100.0% / --
2403: 0.0 / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.02 / 0.01 / -300.0% / 60.0% / -100.0%
2412: -0.01 / -0.01 / 0.0% / -- / 50.0%
2409: -0.02 / -0.02 / 0.0% / -- / 0.0%
2406: -0.02 / -0.01 / -100.0% / -- / 60.0%
2403: -0.05 / -- / -- / 50.0% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 10.0M(--) / -0.2(44.9%)
2212: 0.0(-100.0%) / -0.36306(-7.6%)
2112: 49.21M(--) / -0.337409(89.7%)
2012: 0.0(--) / -3.27078(--)

#MREO

- 사업요약: Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops ...

iCAD, Inc. (ICAD)
시가총액: 106.95M
국가: United States
산업: #Medical_Dental_Instruments
섹터: #Health_Care
홈페이지: https://www.icadmed.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 4.87M / 4.87M / 0.0% / -1.7% / -10.0%
2412: 5.41M / 4.5M / 20.2% / 14.1% / 28.2%
2409: 4.22M / 4.51M / -6.4% / 3.6% / -16.1%
2406: 5.03M / 4.43M / 13.5% / -14.2% / 1.5%
2403: 4.95M / -- / -- / 14.3% / 4.5%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.02 / -0.06 / 66.7% / 60.0% / 33.3%
2412: -0.03 / -0.06 / 50.0% / -160.0% / 99.6%
2409: -7.0 / -0.08 / -8650.0% / -13900.0% / -9900.0%
2406: -0.07 / -0.07 / 0.0% / 0.0% / -40.0%
2403: -0.05 / -- / -- / 66.7% / -200.0%

- 연간 매출(YoY%), EPS(YoY%)
2312: 17.32M(-12.5%) / -0.19(64.8%)
2212: 19.8M(-41.1%) / -0.54(-20.0%)
2112: 33.64M(13.3%) / -0.45(43.8%)
2012: 29.7M(--) / -0.8(--)

#ICAD

- 사업요약: iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digita...

Verrica Pharmaceuticals Inc. (VRCA)
시가총액: 50.85M
국가: United States
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://www.verrica.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 3.44M / 2.48M / 38.7% / -10.1% / 911.8%
2412: 340K / 532.75K / -36.2% / -82.9% / 119.1%
2409: -1.78M / 5.76M / -130.9% / -161.0% / -134.4%
2406: 5.18M / 4.58M / 13.1% / 2746.2% / 35.4%
2403: 3.83M / -- / -- / 10240.5% / 92.5%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.08 / -0.11 / 27.3% / 81.8% / 66.7%
2412: -0.24 / -0.3 / 20.0% / -- / 51.0%
2409: -0.49 / -0.3763 / -30.2% / 9.3% / -32.4%
2406: -0.37 / -0.41 / 9.8% / -54.2% / 15.9%
2403: -0.44 / -- / -- / -193.3% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 5.12M(-43.3%) / --(--)
2212: 9.03M(-24.7%) / -0.72(44.6%)
2112: 12.0M(--) / -1.3(24.0%)
2012: 0.0(--) / -1.71(-51.3%)

#VRCA

- 사업요약: Verrica Pharmaceuticals Inc., a clinical-stage dermatology therapeutics company, develops medications for the treatment of skin diseases in the United States. Its product p...

Avino Silver & Gold Mines Ltd. (ASM)
시가총액: 338.92M
국가: Canada
산업: #Metal_Mining
섹터: #Basic_Materials
홈페이지: https://www.avino.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 18.8M / 17M / 10.6% / 51.7% / -22.9%
2412: 24.38M / 16.7M / 46.0% / 94.6% / 66.8%
2409: 14.62M / 14.55M / 0.5% / 18.7% / -1.1%
2406: 14.79M / 14.35M / 3.1% / 60.4% / 19.3%
2403: 12.39M / -- / -- / 26.1% / -1.1%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: 0.07 / 0.02 / 250.0% / 1454.5% / 133.3%
2412: 0.03 / 0.02 / 50.0% / -- / 200.0%
2409: 0.01 / 0.02 / -50.0% / 200.0% / 0.0%
2406: 0.01 / 0.015 / -33.3% / 0.0% / 122.1%
2403: 0.004503 / -- / -- / 251.7% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 43.89M(-0.7%) / 0.004324(-85.6%)
2212: 44.19M(293.5%) / 0.03(250.0%)
2112: 11.23M(-29.9%) / -0.02(77.8%)
2012: 16.02M(--) / -0.09(--)

#ASM

- 사업요약: Avino Silver & Gold Mines Ltd., together with its subsidiaries, engages in the acquisition, exploration, and advancement of mineral properties in Canada. It primarily explores for silver, gold, and copper...

Absci Corporation (ABSI)
시가총액: 373.72M
국가: United States
산업: #Biotechnology_Commercial_Physical_and_Biological_Resarch
섹터: #Health_Care
홈페이지: https://www.absci.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 1.18M / 2.61M / -54.8% / 31.4% / 68.6%
2412: 700K / 1.8M / -61.1% / 107.1% / -58.8%
2409: 1.7M / 1.75M / -2.9% / 128.5% / 33.9%
2406: 1.27M / 1.91M / -33.5% / -62.3% / 41.4%
2403: 898.0K / -- / -- / -29.2% / 165.7%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.21 / -0.22 / 4.5% / 4.5% / 16.0%
2412: -0.25 / -0.22 / -13.6% / -- / -4.2%
2409: -0.24 / -0.1941 / -23.6% / 0.0% / -9.1%
2406: -0.22 / -0.18 / -22.2% / 51.1% / 0.0%
2403: -0.22 / -- / -- / 15.4% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 5.72M(-0.5%) / --(--)
2212: 5.75M(20.2%) / -1.15(44.7%)
2112: 4.78M(0.0%) / -2.08(-280.0%)
2012: 4.78M(--) / -0.547375(-107.2%)

#ABSI

- 사업요약: Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab ...

Seer, Inc. (SEER)
시가총액: 115.08M
국가: United States
산업: #Biotechnology_Laboratory_Analytical_Instruments
섹터: #Industrials
홈페이지: https://seer.bio

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 4.21M / 3.6M / 16.9% / 38.9% / 5.2%
2412: 4M / 3.95M / 1.3% / -4.3% / 0.0%
2409: 4M / 3.15M / 27.0% / 4.9% / 29.0%
2406: 3.1M / 3.2M / -3.1% / -10.7% / 2.3%
2403: 3.03M / -- / -- / -18.5% / -27.5%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.34 / -0.37 / 8.1% / -6.3% / 8.1%
2412: -0.37 / -0.3667 / -0.9% / -32.1% / -5.7%
2409: -0.35 / -0.31 / -12.9% / -6.1% / 0.0%
2406: -0.35 / -0.36 / 2.8% / 5.4% / -9.4%
2403: -0.32 / -- / -- / 15.8% / -14.3%

- 연간 매출(YoY%), EPS(YoY%)
2312: 15.18M(3.4%) / --(--)
2212: 14.69M(129.7%) / -1.49(-27.4%)
2112: 6.39M(--) / -1.17(52.8%)
2012: 0.0(--) / -2.48(-447.5%)

#SEER

- 사업요약: Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary...

IRIDEX Corporation (IRIX)
시가총액: 18.47M
국가: United States
산업: #Biotechnology_Electromedical_and_Electrotherapeutic_Apparatus
섹터: #Health_Care
홈페이지: https://www.iridex.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 11.9M / 12.1M / -1.7% / 1.2% / -6.3%
2412: 12.7M / 12.8M / -0.8% / 1.9% / 9.7%
2409: 11.58M / 12.5M / -7.4% / -9.9% / -8.3%
2406: 12.63M / 12.9M / -2.1% / -1.8% / 7.4%
2403: 11.76M / -- / -- / -14.2% / -5.6%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.1 / -0.1 / 0.0% / 52.4% / -100.0%
2412: -0.05 / -0.05 / 0.0% / 72.2% / 58.3%
2409: -0.12 / -0.09 / -33.3% / -9.1% / 25.0%
2406: -0.16 / -0.12 / -33.3% / 5.9% / 23.8%
2403: -0.21 / -- / -- / -61.5% / -16.7%

- 연간 매출(YoY%), EPS(YoY%)
2312: 51.87M(-9.0%) / -0.59(-25.5%)
2212: 56.97M(5.7%) / -0.47(-38.2%)
2112: 53.9M(48.3%) / -0.34(26.1%)
2012: 36.35M(--) / -0.46(--)

#IRIX

- 사업요약: IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-...